Pharmaceutical firm's new chairman

DARESBURY-based pharmaceutical company Proveca has appointed the former president of Astra Zeneca UK as chairman.
Chris Brinsmead joins Proveca, which focuses on the re-engineering of existing medicines to make them appropriate for use by young people within Europe, as the company targets continued growth in 2013.
He brings with him more than 30 years experience in the global pharmaceutical industry.
Proveca, which is based at Sci-Tech Daresbury, is currently developing medicines in the fields of cardiology, neurology and pain management, largely for children.
Mr Brinsmead said: “It’s a tremendous honour to be taking this role at such a forward-thinking and progressive company.
“Proveca is consistently making strides in its field and I am confident that my experience and expertise will greatly help with its further development. I look forward to working with the team and playing a key role in the company’s exciting future.”
Proveca director Helen Shaw, the former Medical Director for Boots Healthcare International, said: “We are delighted to be gaining a chairman with such an unparalleled understanding of the pharmaceutical industry as Chris.
Co-director Simon Bryson added: “We’ve enjoyed a fantastic past year and he will be a valued asset to the company as we look to the future and take our pipeline of new products through the process of development.”
Pictured: (L – R) Helen Shaw, Chris Brinsmead and Simon Bryson.